Moreover, hepatic NQO1 and HO-1 protein expression was also increased by myricetin, further indicating that myricetin reversed HFD-induced hepatic steatosis through the Nrf2 pathway, favoring enhancement of antioxidant capacity. This evidence concerns the gene NQO1 and fatty liver disease.